Under conditions of hyperinsulinemia, the pulsatility of insulin secretion is compromised (6), limiting insulin signaling in the hepatocyte, including CEACAM1 phosphorylation, and subsequently, the acute negative effect of insulin on FASN activity is removed to contribute to hyperinsulinemia-driven lipogenesis (11). The gene discussed is FASN; the disease is hyperinsulinism.